| # | Drug | Count |
|---|---|---|
| 0 | NIRAPARIB | 1706 |
| 1 | RUCAPARIB | 556 |
| 2 | OLAPARIB | 222 |
| 3 | BEVACIZUMAB | 184 |
| 4 | ERGOCALCIFEROL | 167 |
| 5 | GABAPENTIN | 140 |
| 6 | LORAZEPAM | 129 |
| 7 | LISINOPRIL | 120 |
| 8 | METOPROLOL TARTRATE | 114 |
| 9 | METOPROLOL | 108 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIPERINE | 1 | 0.2000 |
| 1 | NIRAPARIB | 1706 | 0.0981 |
| 2 | RUCAPARIB | 556 | 0.0674 |
| 3 | FERRIC SUBSULFATE | 1 | 0.0455 |
| 4 | METHENAMINE, BENZOIC ACID, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | 1 | 0.0357 |
| 5 | MIRVETUXIMAB SORAVTANSINE | 3 | 0.0268 |
| 6 | DEXTROSE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | 1 | 0.0256 |
| 7 | OLAPARIB | 222 | 0.0189 |
| 8 | SHARK CARTILAGE | 1 | 0.0128 |
| 9 | PASSION FLOWER | 1 | 0.0123 |
| # | Drug class | Count |
|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1918 |
| 1 | Benzodiazepine [EPC] | 212 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 193 |
| 3 | Provitamin D2 Compound [EPC] | 167 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 165 |
| 5 | Vitamin C [EPC] | 130 |
| 6 | Factor Xa Inhibitor [EPC] | 105 |
| 7 | Corticosteroid [EPC] | 100 |
| 8 | Osmotic Laxative [EPC] | 100 |
| 9 | Platinum-based Drug [EPC] | 100 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1918 | 0.0660 |
| 1 | Nitrogen Binding Agent [EPC] | 1 | 0.0100 |
| 2 | Phenothiazine [EPC] | 48 | 0.0021 |
| 3 | Cannabinoid [EPC] | 12 | 0.0015 |
| 4 | Folate Analog [EPC] | 1 | 0.0015 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 193 | 0.0013 |
| 6 | Methylating Agent [EPC] | 1 | 0.0012 |
| 7 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0011 |
| 8 | Aromatase Inhibitor [EPC] | 91 | 0.0010 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 88 | 0.0009 |